Veronika Felber is a postdoctoral fellow at the LBI:AD. Her research interests include radiometallation as well as preclinical in vitro and in vivo studies, mainly focusing on diagnostic applications with dual-tracers.
She studied chemistry at the Technical University of Munich where, at end of April 2020, she also finished the laboratory work of her PhD at the Chair of Pharmaceutical Radiochemistry (Prof. H.-J. Wester).
Before joining the LBI:AD, she worked on the development and preclinical evaluation of radiolabelled GLP-1 receptor ligands and PSMA inhibitors.